GLOW Study: Effects of Triple Protein in Women

ConditionHealthy Women
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age30-60
SponsorUniversity of North Carolina, Chapel Hill

About this trial

This single-site, randomized, blinded, placebo-controlled study will evaluate whether 4 weeks of daily Triple Support Protein powder improves glycemic control and overall well-being in healthy women aged 30-60 years. Participants will undergo baseline testing (DXA, fasting blood, standardized meal test with 2-hour glucose and insulin sampling), complete one acute supervised dose, and then consume a daily supplement for 4 weeks. During the final 14 days, participants will wear a continuous glucose monitor. Outcomes include postprandial glucose AUC, insulin sensitivity, and body composition.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Females aged 30-60 years.

BMI 18.5-40 kg/m².

Recreationally active (≥30 min/wk moderate intensity exercise).

Healthy and free from disease per health history questionnaire.

Disqualifiers

Currently supplementing whey protein.

Pregnant or nursing.

Lactose intolerant.

Currently using creatine monohydrate.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Triple protein support

    Dietary supplement

    Plant based protein + creatine + fiber

  • Placebo

    Dietary supplement

    Non-caloric matched placebo

Treatment groups

40 Participants
are divided into 2 treatment groups
Group A: Triple Protein SupportExperimental treatment 1 intervention
Group B: PlaceboPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in postprandial glucose area under the curve (AUC)

Glucose measured at 0-120 minutes post-meal; AUC by trapezoidal method.

Time frame
Glucose measured over 0-120 minutes starting post standardized meal

Secondary outcomes

1

Change in insulin sensitivity (HOMA-IR)

Calculated from fasting glucose and insulin.

Time frame
Baseline, Week 6
2

Change in lean soft tissue

Lean soft tissue measured from whole body dual energy x-ray absorptiometry

Time frame
Baseline, week 6

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.